CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Multiple Sclerosis-Simvastatin Trial 2 [Phase 3]
Summary
Phase 3 trial evaluating simvastatin for secondary progressive multiple sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College, London | Conditions: Secondary Progressive Multiple Sclerosis (SPMS) | Phase 3 | Status: COMPLETED